微信小陈
微信小章| 产品名称： | Streptococcus agalactiae Lehmann and Neumann |
|---|---|
| 商品货号： | TS187390 |
| Strain Designations： | CJB 111 |
| Application： | Produces capsular polysaccharide type V |
| Isolation： | Blood, 1990 |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Antigenic Properties： | Serotype V (Carol J Baker, personal communication) |
| Product Format： | freeze-dried |
| Storage Conditions： | Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section |
| Preceptrol®： | no |
| Genome Sequenced Strain： | Yes |
| Type Strain： | no |
| Comments： | Genome sequenced strain |
| Medium： | ATCC® Medium 44: Brain Heart Infusion Agar/Broth ATCC® Medium 260: Trypticase soy agar/broth with defibrinated sheep blood |
| Growth Conditions： | Temperature: 37°C Atmosphere: Aerobic |
| Name of Depositor： | CJ Baker |
| Special Collection： | NCRR Contract |
| Year of Origin： | 1990 |
| References： | Carol J Baker, personal communication Tettelin H, et al. Genome analysis of multiple pathogenic isolates of Streptococcus agalactiae: implications for the microbial "pan-genome". Proc. Natl. Acad. Sci. USA. 102(39): 13950-13955, 2005. PubMed: 16172379 Carol J Baker, personal communication Carol J Baker, personal communication |
| Cross References： | Nucleotide (GenBank) : AAJQ01000000 Streptococcus agalactiae CJB111, whole genome shotgun sequencing project |